🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with oral semaglutide 50mg (rybelsus hd)? Page 7

Has anyone dealt with oral semaglutide 50mg (rybelsus hd)?

Dr.SleepRoch Wed, Apr 16, 2025 at 7:41 AM 33 replies 1,762 viewsPage 7 of 7
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Apr 22, 2025 at 10:27 AM#31
BariatricNurseD said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

There is a second half to this that has not been said yet. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

Last edited: Apr 22, 2025 at 1:27 PM
5 3DataDave, Dr.GutHealth, amsterdam_pete and 2 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Apr 22, 2025 at 4:50 PM#32

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

6 4maya_sedona, stefan_berlin, Dr.EM_Chicago and 3 others
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Apr 22, 2025 at 11:13 PM#33

Following on from BariatricNurseD — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

Last edited: Apr 23, 2025 at 5:13 AM
7 5ZaraB_AL, JakeSmashed95, NauseaFreeNow and 4 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Apr 23, 2025 at 5:36 AM#34
lisa_labSD said:
Keep the original post as written when you update it, and add the correction underneath.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

8 6jennifer_SEA, tyler_CSCS, VanRx_Mike and 5 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Apr 23, 2025 at 11:59 AM#35
lisa_labSD said:
Keep the original post as written when you update it, and add the correction underneath.

That holds where the measurement is reliable. Where it is noisy — and a lot of what gets tracked here is noisy — the same reasoning produces confident nonsense.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

9 7carl_compliance, DanielChem_CHI, marco_milano and 6 others
Reply Quote Save Share Report
1567

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register